Download
13054_2024_Article_5142.pdf 2,10MB
WeightNameValue
1000 Titel
  • Effect of therapeutic plasma exchange on tissue factor and tissue factor pathway inhibitor in septic shock
1000 Autor/in
  1. Stahl, Klaus |
  2. Lehner, Georg F. |
  3. Wendel-Garcia, Pedro David |
  4. Seeliger, Benjamin |
  5. Pape, Thorben |
  6. Schmidt, Bernhard M. W. |
  7. Schenk, Heiko |
  8. Schmitt, Julius |
  9. Sauer, Andrea |
  10. Wild, Lennart |
  11. Peukert, Konrad |
  12. Putensen, Christian |
  13. Bode, Christian |
  14. Joannidis, Michael |
  15. David, Sascha |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-10-30
1000 Erschienen in
1000 Quellenangabe
  • 28(1):351
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13054-024-05142-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11526504/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Coagulopathy is part of the pathological host response to infection in sepsis. Higher plasma concentrations of both tissue factor (TF) and tissue factor pathway inhibitor (TFPI) are associated with occurrence of disseminated intravascular coagulation (DIC), multi-organ dysfunction and increased mortality in patients with sepsis. Currently no treatment approaches specifically targeting this axis are available. We hypothesize that therapeutic plasma exchange (TPE) might limit this coagulopathy by restoring the balance of plasma proteins.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>This was a pooled post-hoc biobank analysis including 51 patients with early (shock onset &lt; 24 h) and severe (norepinephrine dose &gt; 0.4 μg/kg/min) septic shock, who were either receiving standard of care treatment (SOC, n = 14) or SOC + one single TPE (n = 37). Plasma concentrations of TF and TFPI were measured both at- and 6 h after study inclusion. The effect of TPE on concentrations of TF and TFPI was investigated and compared to SOC patients. Further, baseline TF and TFPI concentrations were used to modulate and predict clinical response to adjunctive TPE, indicated by longitudinal reduction of lactate concentrations over the first 24 h following study inclusion.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>TPE led to a significant reduction in circulating concentrations of both TF and TFPI while no difference was observed in the SOC group. Relative change of TF within 6 h was + 14 (-0.8 to + 30.4) % (p = 0.089) in the SOC and −18.3 (−32.6 to −2.2) % (p &lt; 0.001) in the TPE group (between group p &lt; 0.001). Similarly, relative change of TFPI was + 14.4 (−2.3 to + 30.9) % (p = 0.076) in the SOC and −20 (−32.8 to −7.9) % (p &lt; 0.001) in the TPE group (between group p = 0.022). The ratio of TF to TFPI remained unchanged in both SOC and TPE groups. SOC patients exhibited an increase in lactate over the initial 24 h when TF and TFPI concentrations were higher at baseline. In contrast, patients undergoing TPE experienced a sustained longitudinal reduction of lactate concentrations across all levels of baseline TF and TFPI elevations. In a multivariate mixed−effects model, higher baseline TF (p = 0.003) and TFPI (p = 0.053) levels led to greater longitudinal lactate concentration reduction effects in the TPE group.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Adjunctive TPE in septic shock is associated with a significant removal of both TF and TFPI, which may contribute to the early hemodynamic improvement observed in septic shock patients receiving TPE. Higher baseline TF (and TFPI) plasma concentrations were identified as a putative predictor of treatment response that could be useful for predictive enrichment strategies in future clinical trials.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Plasma Exchange/methods [MeSH]
lokal Female [MeSH]
lokal Extracorporeal treatment
lokal Aged [MeSH]
lokal Thromboplastin/metabolism [MeSH]
lokal Humans [MeSH]
lokal Middle Aged [MeSH]
lokal Lipoproteins/blood [MeSH]
lokal Thromboplastin/analysis [MeSH]
lokal Precision medicine
lokal Tissue factor
lokal Plasmapheresis
lokal Male [MeSH]
lokal Research
lokal Shock, Septic/blood [MeSH]
lokal Sepsis
lokal Coagulation
lokal Tissue factor pathway inhibitor
lokal Shock, Septic/therapy [MeSH]
lokal Apheresis
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U3RhaGwsIEtsYXVz|https://frl.publisso.de/adhoc/uri/TGVobmVyLCBHZW9yZyBGLg==|https://frl.publisso.de/adhoc/uri/V2VuZGVsLUdhcmNpYSwgUGVkcm8gRGF2aWQ=|https://frl.publisso.de/adhoc/uri/U2VlbGlnZXIsIEJlbmphbWlu|https://frl.publisso.de/adhoc/uri/UGFwZSwgVGhvcmJlbg==|https://frl.publisso.de/adhoc/uri/U2NobWlkdCwgQmVybmhhcmQgTS4gVy4=|https://frl.publisso.de/adhoc/uri/U2NoZW5rLCBIZWlrbw==|https://frl.publisso.de/adhoc/uri/U2NobWl0dCwgSnVsaXVz|https://frl.publisso.de/adhoc/uri/U2F1ZXIsIEFuZHJlYQ==|https://frl.publisso.de/adhoc/uri/V2lsZCwgTGVubmFydA==|https://frl.publisso.de/adhoc/uri/UGV1a2VydCwgS29ucmFk|https://frl.publisso.de/adhoc/uri/UHV0ZW5zZW4sIENocmlzdGlhbg==|https://frl.publisso.de/adhoc/uri/Qm9kZSwgQ2hyaXN0aWFu|https://frl.publisso.de/adhoc/uri/Sm9hbm5pZGlzLCBNaWNoYWVs|https://frl.publisso.de/adhoc/uri/RGF2aWQsIFNhc2NoYQ==
1000 Hinweis
  • DeepGreen-ID: 3c67f6a9eae64c3b8c471f89a7705f70 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Medizinische Hochschule Hannover (MHH) |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Medizinische Hochschule Hannover (MHH) |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6522156.rdf
1000 Erstellt am 2025-07-06T12:52:04.429+0200
1000 Erstellt von 322
1000 beschreibt frl:6522156
1000 Zuletzt bearbeitet 2025-07-31T15:15:27.449+0200
1000 Objekt bearb. Thu Jul 31 15:15:27 CEST 2025
1000 Vgl. frl:6522156
1000 Oai Id
  1. oai:frl.publisso.de:frl:6522156 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source